You are viewing the site in preview mode

Skip to main content

Table 3 Outcomes comparing Observation vs CLND in SLNB positive patients

From: Lymphadenectomy after a positive sentinel node biopsy in patients with cutaneous melanoma. A systematic review

AUTOR OS 3y p OS 5y p MSS-3y p MSS-5y p DFS-3y p DFS-5y p
Obs. CLND   Obs. CLND   Obs. CLND   Obs. CLND   Obs. CLND   Obs. CLND  
Bamboat (Bamboat et al., 2014)        79%a 73%a 0.09 69%a 62%a 0.09 37%a 50%a   29%a 41%a  
Satzger (Satzger et al., 2014)           81%a 71%a      71%a 56%a  
Ploeg (van der Ploeg et al., 2014)                   
Melstrom (Melstrom et al., 2014)     35%a 37%a 0.6             
Gyorki (Gyorki et al., 2014)                 33% 40% 0.34
Fritsch (Fritsch et al., 2016)                   
Mosquera (Mosquera et al., 2017)           70% 72% 0.83       
Lee (Lee et al., 2016)           66% 74% 0.015     55% 49% 0.21
Faries (Faries et al., 2017)        86% 86% 0.42     63% 68% 0.05    
Klemen (Klemen et al., 2019)     59% 64% 0.084     66% 71% 0.161       
Leiter (Leiter et al., 2019) 82% 81% 0.87 71% 72% 0.94        67% 67% 0.75 61% 60% 0.94
  1. Obs Observation, CLND Completion lymph node lymphadenectomy, Obs. Observation, OS Overall Survival, MSS Melanoma specific survival, DFS Disease free survival. aData extracted by software (PlotDigitizer®)
Back to article page

Surgical and Experimental Pathology

ISSN: 2520-8454

Contact us